AstraZeneca is a global, science-led biopharmaceutical company that focuses on the discovery, development and commercialization of prescription medicines, primarily for the treatment of diseases in three therapy areas – Oncology, Cardiovascular, Renal & Metabolism and Respiratory. For more information, please visit www.astrazeneca-us.com and follow us on Twitter @AstraZenecaUS.
LYNPARZA® (olaparib) Representative: Natasha Rowan
LYNPARZA® (olaparib) Representative: Scott Fredericksen
TAGRISSO® (osimertinib) Representative: Danielle Allison
IMFINZI® (durvalumab) Representative: David Reece
ADC Franchise Representative: Cindy Ewald-Smidt